Aquapharm Biodiscovery

United Kingdom
Newyork, Argyll and Bute, United Kingdom, PA37 1QA

Company profile

Aquapharm Biodiscovery company profile

Aquapharm is an innovative drug discovery company focussed on developing new products founded on the chemical diversity of marine micro-organisms. Their core focus is the development of novel pharmaceutical compounds leading to the development of novel antibiotics, targeting both Gram negative and Gram positive infections. In addition, Aquapharm's development pipeline is also fed by an active discovery portfolio of anti-oxidants, anti-inflammatories and novel biocatalysts.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2000-01-01, Year

Headquarters

Postal code
PA37 1QA
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
3
Total equity funding
$16.2M
Last funding
Series C / $6.4M / 2010-04-05
Last equity funding
Series C / $6.4M
Investors
6
Lead investors
1
Founders
1
Articles
1

Founders and investors

Founders

Andrew Mearns Spragg

Lead investors

Aescap Venture

Investors

Aescap VentureHighlands and Islands EnterpriseNesta VenturesScottish Investment BankTate & Lyle Ventures